Stigma

This report aims to address the treatment opportunities for pregnant and postpartum (or parenting) women (PPW) with substance use disorder (SUD) by describing opportunities to integrate obstetricians and gynecologists (OB/GYN) and SUD care as well as barriers to integrated care delivery.

This toolkit is tailored specifically to the unique needs of multidisciplinary substance use disorder (SUD) providers and programs serving perinatal individuals. It is meant to be a quick reference resource about mental health and SUD specific to perinatal individuals.

This web page outlines policies on substance use during pregnancy, categorizing how these policies differ from state to state.

This is the first in a series of articles on state policies that support or inhibit postpartum women’s (PPWs’) access to long-term recovery from opioid-use disorders (OUDs). It reviews current federal and state policies on mandatory reporting by health care professionals of a patient's substance use during pregnancy and their implications

This Guide to meant to help health care teams recognize, rethink and remediate the stigma and bias of words commonly used in caring for people with the chronic disease of substance use disorder:

This resource offers background information and tips for providers on how to use person-first language and on which terms to avoid using to reduce stigma and negative bias when discussing addiction or substance use disorder with pregnant women and mothers.

MCPAP for Moms provides obstetricians, midwives, and PCPs with psychiatric consultation for behavioral health concerns and questions around medications when pregnant or breastfeeding. MCPAP for Moms also supports connections with community-based services and support groups.

This implementation guide serves to provide other medical clinics seeking to integrate maternal mental health care into obstetric and/or pediatric settings with best practices for doing so.

This report describes changes in drug overdose death rates from 2019 to 2020, stratified by sex, age group, and race and ethnicity. In addition, it examines differences in circumstances surrounding drug overdose, and assesses differences in overdose death rates by county-level income inequality and availability of mental health treatment providers and providers of medications for opioid use disorder.

A summary of a workshop from the National Institutes of Health (NIH) HEAL (Helping to End Addiction Long-Term) Initiative, discussing opioid use in the context of polysubstance use.